Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC, 35692-35693 [2019-15739]
Download as PDF
<![CDATA[
35692
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
The company plans to import the
listed controlled substance in bulk for
manufacture of analytical reference
material which, in its final form, is an
exempted product.
Dated: July 15, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–15738 Filed 7–23–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
DATES:
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on May 7,
2019, AMRI Rensselaer, Inc., 33
Riverside Avenue, Rensselaer, New
York 12144 applied to be registered as
an importer of the following basic class
of controlled substance:
Controlled substance
Drug code
Poppy Straw
Concentrate.
9670
Schedule
II
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Drug Enforcement Administration Bulk
Manufacturer of Controlled
Substances Application: IsoSciences,
LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 23, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
The company plans to import the
listed controlled substance to
manufacture a bulk controlled substance
for distribution to its customers.
Dated: July 15, 2019.
John J. Martin,
Assistant Administrator.
In accordance with 21 CFR
1301.33(a), this is notice that on May 21,
2019, IsoSciences, LLC, 340 Mathers
Road, Ambler, Pennsylvania 19002–
3420 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
[FR Doc. 2019–15737 Filed 7–23–19; 8:45 am]
BILLING CODE 4410–09–P
Drug
code
khammond on DSKBBV9HB2PROD with NOTICES
Controlled substance
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
Lysergic acid diethylamide ......................................................................................................................................................
Marihuana ................................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
Dihydromorphine .....................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
PO 00000
Frm 00105
Fmt 4703
Sfmt 4703
E:\FR\FM\24JYN1.SGM
24JYN1
1235
1237
7315
7360
7370
7400
7404
7405
7431
7432
7433
7434
7435
7437
7438
7439
9145
9200
9309
9312
9313
9315
9635
9811
9812
9813
9814
9815
9816
9821
9822
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
35693
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
Drug
code
Controlled substance
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................................
Thiofentanyl .............................................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Amphetamine ...........................................................................................................................................................................
Methamphetamine ...................................................................................................................................................................
Codeine ...................................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Oxycodone ...............................................................................................................................................................................
Hydromorphone .......................................................................................................................................................................
Hydrocodone ...........................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Methadone ...............................................................................................................................................................................
Methadone intermediate ..........................................................................................................................................................
Morphine ..................................................................................................................................................................................
Thebaine ..................................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................................
Oxymorphone ..........................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Fentanyl ...................................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
analytical testing. In reference to drug
codes 7360 (marihuana) and 7370
(THC), the company plans to bulk
manufacture these drugs as synthetics.
No other activities for these drug codes
are authorized for this registration.
Dated: July 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–15739 Filed 7–23–19; 8:45 am]
BILLING CODE 4410–09–P
LEGAL SERVICES CORPORATION
Sunshine Act Meeting
The Legal Services
Corporation’s Board of Directors and its
six committees will meet July 28–30,
2019. On Sunday, July 28, the first
meeting will commence at 12:30 p.m.,
Eastern Daylight Time (EDT), with the
meetings thereafter commencing
promptly upon adjournment of the
immediately preceding meeting. On
Monday, July 29, the first meeting will
commence at 9:30 a.m. (EDT), with the
next meeting commencing promptly
upon adjournment of the immediately
preceding meeting. The closed session
meeting of the Board of Directors will
commence promptly upon adjournment
of the open session of the Board of
Directors meeting.
khammond on DSKBBV9HB2PROD with NOTICES
TIME AND DATE:
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
The Courtyard by Marriott
Portland, Downtown Waterfront, 321
Commercial Street, Portland, Maine
04101.
PLACE:
Unless otherwise noted herein,
the Board and all committee meetings
will be open to public observation.
Members of the public who are unable
to attend in person but wish to listen to
the public proceedings may do so by
following the telephone call-in
directions provided below.
Call-in Directions for Open Sessions:
• Call toll-free number: 1–866–451–
4981;
• When prompted, enter the
following numeric pass code:
5907707348.
• Once connected to the call, your
telephone line will be automatically
‘‘MUTED’’.
• To participate in the meeting during
public comment press #6 to ‘‘UNMUTE’’
your telephone line, once you have
concluded your comments please press
*6 to ‘‘MUTE’’ your line.
Members of the public are asked to
keep their telephones muted to
eliminate background noises. To avoid
disrupting the meeting, please refrain
from placing the call on hold if doing so
will trigger recorded music or other
sound. From time to time, the presiding
Chair may solicit comments from the
public.
STATUS:
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
9824
9825
9830
9831
9832
9833
9834
9835
9836
9843
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
Schedule
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Meeting Schedule
Sunday, July 28, 2019: Time: * 12:30
p.m.
1. Operations & Regulations Committee
2. Governance and Performance Review
Committee
3. Communications Subcommittee
Committee
4. Institutional Advancement
Committee
Monday, July 29, 2019: 9:30 a.m.
1. Audit Committee
2. Delivery of Legal Services Committee
Tuesday, July 30, 2019: 8:00 a.m.
1. Finance Committee
2. Board of Directors
Status of Meeting: Open, except as
noted below.
Board of Directors—Open, except
that, upon a vote of the Board of
Directors, a portion of the meeting may
be closed to the public to hear briefings
by management and LSC’s Inspector
General, and to consider and act on the
General Counsel’s report on potential
and pending litigation involving LSC,
and on a list of prospective funders.**
* Please note that all times in this notice are in
Eastern Daylight Time.
** Any portion of the closed session consisting
solely of briefings does not fall within the Sunshine
Act’s definition of the term ‘‘meeting’’ and,
therefore, the requirements of the Sunshine Act do
not apply to such portion of the closed session. 5
E:\FR\FM\24JYN1.SGM
Continued
24JYN1
]]>Agencies
[Federal Register Volume 84, Number 142 (Wednesday, July 24, 2019)]
[Notices]
[Pages 35692-35693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15739]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[Docket No. DEA-392]
Drug Enforcement Administration Bulk Manufacturer of Controlled
Substances Application: IsoSciences, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before September 23, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on May
21, 2019, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania
19002-3420 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone................................... 1235 I
Methcathinone............................... 1237 I
Lysergic acid diethylamide.................. 7315 I
Marihuana................................... 7360 I
Tetrahydrocannabinols....................... 7370 I
3,4-Methylenedioxyamphetamine............... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine....... 7404 I
3,4-Methylenedioxymethamphetamine........... 7405 I
5-Methoxy-N-N-dimethyltryptamine............ 7431 I
Alpha-methyltryptamine...................... 7432 I
Bufotenine.................................. 7433 I
Diethyltryptamine........................... 7434 I
Dimethyltryptamine.......................... 7435 I
Psilocybin.................................. 7437 I
Psilocyn.................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
Dihydromorphine............................. 9145 I
Heroin...................................... 9200 I
Nicocodeine................................. 9309 I
Nicomorphine................................ 9312 I
Normorphine................................. 9313 I
Thebacon.................................... 9315 I
Normethadone................................ 9635 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl......................... 9812 I
3-Methylfentanyl............................ 9813 I
Alpha-methylfentanyl........................ 9814 I
Acetyl-alpha-methylfentanyl................. 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I
yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl............................ 9822 I
[[Page 35693]]
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Beta-hydroxyfentanyl........................ 9830 I
Beta-hydroxy-3-methylfentanyl............... 9831 I
Alpha-methylthiofentanyl.................... 9832 I
3-Methylthiofentanyl........................ 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................ 9835 I
Beta-hydroxythiofentanyl.................... 9836 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Amphetamine................................. 1100 II
Methamphetamine............................. 1105 II
Codeine..................................... 9050 II
Dihydrocodeine.............................. 9120 II
Oxycodone................................... 9143 II
Hydromorphone............................... 9150 II
Hydrocodone................................. 9193 II
Isomethadone................................ 9226 II
Methadone................................... 9250 II
Methadone intermediate...................... 9254 II
Morphine.................................... 9300 II
Thebaine.................................... 9333 II
Levo-alphacetylmethadol..................... 9648 II
Oxymorphone................................. 9652 II
Thiafentanil................................ 9729 II
Alfentanil.................................. 9737 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Fentanyl.................................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in analytical testing. In reference to drug codes 7360 (marihuana) and
7370 (THC), the company plans to bulk manufacture these drugs as
synthetics. No other activities for these drug codes are authorized for
this registration.
Dated: July 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-15739 Filed 7-23-19; 8:45 am]
BILLING CODE 4410-09-P
